Center for Financing, Access, and Cost Trends (CFACT): Publications by Staff

Eric Sarpong

Authors: Miller GE, Sarpong E
Title: Trends in the pharmaceutical treatment of children's asthma, 1997-1998 to 2007-2008
Publication: MEPS Research Findings No. 31. Available on the MEPS Web site.
Date: September 2011
Abstract: Among children with reported treatment for asthma, trends are examined in the use and expenditures of three major types of medications: controllers, relievers, and oral corticosteroids. Expenditures for controllers accounted for about 90 percent of increased spending. Differences in controller use persisted in 2007-2008, as minority, publicly insured and poor and low income children were less likely than others to use these medications and were more likely to use relievers only.

Authors: Sarpong E, Miller GE
Title: Changes in children's use and expenditures for asthma medications, United States, 1997-1998 to 2007-2008
Publication: MEPS Statistical Brief No. 341. Available on the MEPS Web site.
Date: September 2011
Abstract: This Statistical Brief examines changes in medication use and expenditures among children with reported treatment for asthma from 1997-1998 to 2007-2008. Overall, the average annual proportion of children with reported treatment for asthma in the U.S. increased from 4.7 percent in 1997-1998 to 6.1 percent in 2007-2008.

Authors: Sarpong E, Miller GE
Title: Asthma medication use among children with reported treatment for asthma, United States, 2007-2008
Publication: MEPS Statistical Brief No. 340. Available on the MEPS Web site.
Date: September 2011
Abstract: This Statistical Brief examines controller and reliever use across groups of children by race/ethnicity, sex, income, health insurance status, and Census region data from 2007 and 2008.

Author: Sarpong E
Title: Health expenditures among children with reported treatment for asthma, United States, 1997-1998 and 2007-2008
Publication: MEPS Statistical Brief No. 332. Available on the MEPS Web site.
Date: July 2011
Abstract: This Statistical Brief compares estimates of health expenditures for children with reported treatment for asthma in 1997-1998 and 2007-2008 using data from the Household Component of the Medical Expenditure Panel Survey. The estimates are based on a sample of children younger than 18 years of age with reported treatment associated with asthma during the year. The average annual proportion of children reporting treatment for asthma in the U.S. increased slightly from 4.7 percent in 1997-1998 to 6.1 percent in 2007-2008. In particular, there were increases in the proportion of children ages 5-11 and ages 12-17, with reported treatment for asthma over the period.

Authors: Sarpong E, Miller GE
Title: Trends in pharmaceutical treatment of diabetes: A comparison of utilization and expenditures, 1997 to 2007
Publication: MEPS Statistical Brief No. 293. Available on the MEPS Web site.
Date: September 2010
Abstract: In this Statistical Brief, we present estimates based on data from the Household Component of the Medical Expenditure Panel Survey (MEPS-HC) on trends from 1997 to 2007 in anti-diabetic medication use and expenditures in the U.S. civilian noninstitutionalized population. The sample is composed of persons with diagnosed diabetes who reported treatment for diabetes during the year. Between 1997 and 2007, the total number of persons with diabetes who reported using oral anti-diabetic medications more than doubled, from 5.9 million to 14.6 million. In 1997, 3.7 million persons who reported treatment for diabetes were using insulin compared with 4.6 million in 2007.

Authors: Sarpong E, Miller GE
Title: Trends in the pharmaceutical treatment of diabetes, 1997 to 2007
Publication: MEPS Research Findings No. 30. Available on the MEPS Web site.
Date: September 2010
Abstract: In addition to investigating aggregate trends in drug utilization among persons reporting treatment for diabetes, we examine anti-diabetic medication use in subgroups of this population. In particular, we examine trends within and differences across groups defined by age, race/ethnicity, health insurance, income, and education. Results presented for selected population characteristics and drug expenditures are estimated using pooled data for 1997-1998 and 2006-2007.

---

 Previous Section       CFACT Author Index       Next Section 

---